Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Kezar Life Sciences, Inc. (KZR) had Earnings per Share (EPS) (Basic) of $-1.40 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$7.00M |
|
$-101.87M |
|
-- |
|
$7.00M |
|
$118.42M |
|
$-111.42M |
|
$9.55M |
|
$-101.87M |
|
$-101.87M |
|
$-101.87M |
|
$-101.87M |
|
$-101.87M |
|
$-101.87M |
|
$-111.42M |
|
$-116.95M |
|
72.55M |
|
72.55M |
|
|
Earnings per Share (EPS) (Basic) |
$-1.40 |
$-1.40 |
|
| Balance Sheet Financials | |
$206.95M |
|
$3.91M |
|
$14.29M |
|
$221.24M |
|
$17.74M |
|
$10.07M |
|
$15.92M |
|
$33.66M |
|
$187.57M |
|
$187.57M |
|
$187.57M |
|
72.78M |
|
| Cash Flow Statement Financials | |
$-81.64M |
|
$76.05M |
|
$0.64M |
|
$40.46M |
|
$35.49M |
|
$-4.96M |
|
$18.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.66 |
|
-- |
|
-- |
|
0.05 |
|
0.05 |
|
100.00% |
|
-1591.77% |
|
-1591.77% |
|
-1670.76% |
|
-1455.29% |
|
-1455.29% |
|
$-83.45M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-54.31% |
|
-54.31% |
|
-46.05% |
|
-51.54% |
|
$2.58 |
|
$-1.15 |
|
$-1.13 |
|